annual total liabilities:
$62.64B+$5.56B(+9.75%)Summary
- As of today (August 22, 2025), NVS annual total liabilities is $62.64 billion, with the most recent change of +$5.56 billion (+9.75%) on December 31, 2024.
- During the last 3 years, NVS annual total liabilities has fallen by -$5.42 billion (-7.97%).
- NVS annual total liabilities is now -17.06% below its all-time high of $75.52 billion, reached on December 31, 2020.
Performance
NVS Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$62.34B+$851.93M(+1.39%)Summary
- As of today (August 22, 2025), NVS quarterly total liabilities is $62.34 billion, with the most recent change of +$851.93 million (+1.39%) on June 30, 2025.
- Over the past year, NVS quarterly total liabilities has increased by +$6.74 billion (+12.12%).
- NVS quarterly total liabilities is now -31.22% below its all-time high of $90.64 billion, reached on March 31, 2019.
Performance
NVS quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NVS Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.8% | +12.1% |
| 3 y3 years | -8.0% | +4.1% |
| 5 y5 years | -0.4% | -10.8% |
NVS Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.0% | +9.8% | -16.3% | +14.2% |
| 5 y | 5-year | -17.1% | +9.8% | -17.4% | +14.2% |
| alltime | all time | -17.1% | +390.5% | -31.2% | +388.2% |
NVS Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $62.34B(+1.4%) |
| Mar 2025 | - | $61.49B(-1.8%) |
| Dec 2024 | $62.64B(+9.7%) | $62.64B(+4.3%) |
| Sep 2024 | - | $60.08B(+8.1%) |
| Jun 2024 | - | $55.60B(+1.9%) |
| Mar 2024 | - | $54.58B(-4.4%) |
| Dec 2023 | $57.07B(-8.5%) | $57.07B(-23.3%) |
| Sep 2023 | - | $74.45B(+26.1%) |
| Jun 2023 | - | $59.05B(-1.7%) |
| Mar 2023 | - | $60.10B(-3.6%) |
| Dec 2022 | $62.34B(-8.4%) | $62.34B(+8.3%) |
| Sep 2022 | - | $57.57B(-3.9%) |
| Jun 2022 | - | $59.90B(-5.7%) |
| Mar 2022 | - | $63.51B(-6.7%) |
| Dec 2021 | $68.06B(-9.9%) | $68.06B(+5.9%) |
| Sep 2021 | - | $64.27B(-8.0%) |
| Jun 2021 | - | $69.89B(-1.8%) |
| Mar 2021 | - | $71.16B(-5.8%) |
| Dec 2020 | $75.52B(+20.1%) | $75.52B(+0.5%) |
| Sep 2020 | - | $75.12B(+7.5%) |
| Jun 2020 | - | $69.88B(-3.1%) |
| Mar 2020 | - | $72.12B(+14.7%) |
| Dec 2019 | $62.86B(-6.1%) | $62.86B(-0.8%) |
| Sep 2019 | - | $63.37B(-2.2%) |
| Jun 2019 | - | $64.79B(-28.5%) |
| Mar 2019 | - | $90.64B(+35.4%) |
| Dec 2018 | $66.95B(+13.5%) | $66.95B(+3.0%) |
| Sep 2018 | - | $64.97B(-0.3%) |
| Jun 2018 | - | $65.16B(+1.3%) |
| Mar 2018 | - | $64.31B(+9.0%) |
| Dec 2017 | $59.00B(+6.3%) | $59.00B(-5.7%) |
| Sep 2017 | - | $62.60B(-1.8%) |
| Jun 2017 | - | $63.77B(-0.9%) |
| Mar 2017 | - | $64.34B(+15.9%) |
| Dec 2016 | $55.50B(+1.3%) | $55.50B(-5.8%) |
| Sep 2016 | - | $58.94B(+0.1%) |
| Jun 2016 | - | $58.90B(-2.7%) |
| Mar 2016 | - | $60.56B(+10.5%) |
| Dec 2015 | $54.78B(-0.3%) | $54.78B(-2.4%) |
| Sep 2015 | - | $56.14B(-0.8%) |
| Jun 2015 | - | $56.58B(-3.3%) |
| Mar 2015 | - | $58.49B(+6.5%) |
| Dec 2014 | $54.92B(+5.3%) | $54.92B(+1.8%) |
| Sep 2014 | - | $53.95B(-2.3%) |
| Jun 2014 | - | $55.25B(+0.5%) |
| Mar 2014 | - | $55.00B(+5.5%) |
| Dec 2013 | $52.15B(-5.1%) | $52.15B(-0.5%) |
| Sep 2013 | - | $52.41B(+1.9%) |
| Jun 2013 | - | $51.44B(-4.5%) |
| Mar 2013 | - | $53.86B(-1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $54.93B(+6.5%) | $54.93B(+1.7%) |
| Sep 2012 | - | $54.01B(-0.4%) |
| Jun 2012 | - | $54.25B(-3.5%) |
| Mar 2012 | - | $56.21B(+9.0%) |
| Dec 2011 | $51.56B(-3.9%) | $51.56B(-6.7%) |
| Sep 2011 | - | $55.24B(-6.1%) |
| Jun 2011 | - | $58.82B(-4.9%) |
| Mar 2011 | - | $61.88B(+15.3%) |
| Dec 2010 | $53.67B(+41.1%) | $53.67B(-8.1%) |
| Sep 2010 | - | $58.41B(+42.1%) |
| Jun 2010 | - | $41.11B(+1.3%) |
| Mar 2010 | - | $40.58B(+6.7%) |
| Dec 2009 | $38.04B(+36.5%) | $38.04B(+2.0%) |
| Sep 2009 | - | $37.31B(+11.2%) |
| Jun 2009 | - | $33.55B(+4.8%) |
| Mar 2009 | - | $32.01B(+14.9%) |
| Dec 2008 | $27.86B(+23.9%) | $27.86B(-8.8%) |
| Sep 2008 | - | $30.56B(-3.9%) |
| Jun 2008 | - | $31.79B(-4.6%) |
| Mar 2008 | - | $33.31B(+48.1%) |
| Dec 2007 | $22.49B(-1.4%) | $22.49B(-18.1%) |
| Sep 2007 | - | $27.44B(+1.4%) |
| Jun 2007 | - | $27.05B(-2.1%) |
| Mar 2007 | - | $27.64B(+21.2%) |
| Dec 2006 | $22.81B(+7.8%) | $22.81B(-19.1%) |
| Sep 2006 | - | $28.18B(-2.7%) |
| Jun 2006 | - | $28.95B(+16.0%) |
| Mar 2006 | - | $24.97B(+18.0%) |
| Dec 2005 | $21.17B(-0.3%) | $21.17B(-8.1%) |
| Sep 2005 | - | $23.03B(+1.8%) |
| Jun 2005 | - | $22.63B(+11.8%) |
| Mar 2005 | - | $20.24B(-4.6%) |
| Dec 2004 | $21.23B(+29.1%) | $21.23B(+12.1%) |
| Sep 2004 | - | $18.94B(+3.0%) |
| Jun 2004 | - | $18.39B(-2.9%) |
| Mar 2004 | - | $18.94B(+15.2%) |
| Dec 2003 | $16.44B(-3.0%) | $16.44B(+11.6%) |
| Dec 2002 | $16.94B(+32.7%) | $14.73B(-3.6%) |
| Sep 2002 | - | $15.29B(+1.5%) |
| Jun 2002 | - | $15.06B(+17.9%) |
| Dec 2001 | $12.77B(-2.6%) | $12.77B(-8.3%) |
| Jun 2001 | - | $13.92B(+5.7%) |
| Dec 2000 | $13.12B(-25.3%) | $13.17B(-15.5%) |
| Jun 2000 | - | $15.58B |
| Dec 1999 | $17.55B(+14.2%) | - |
| Dec 1998 | $15.36B(-9.7%) | - |
| Dec 1997 | $17.00B(-24.0%) | - |
| Dec 1996 | $22.36B(-2.9%) | - |
| Dec 1995 | $23.02B(+5.3%) | - |
| Dec 1994 | $21.86B(+35.7%) | - |
| Dec 1993 | $16.11B | - |
FAQ
- What is Novartis AG annual total liabilities?
- What is the all time high annual total liabilities for Novartis AG?
- What is Novartis AG annual total liabilities year-on-year change?
- What is Novartis AG quarterly total liabilities?
- What is the all time high quarterly total liabilities for Novartis AG?
- What is Novartis AG quarterly total liabilities year-on-year change?
What is Novartis AG annual total liabilities?
The current annual total liabilities of NVS is $62.64B
What is the all time high annual total liabilities for Novartis AG?
Novartis AG all-time high annual total liabilities is $75.52B
What is Novartis AG annual total liabilities year-on-year change?
Over the past year, NVS annual total liabilities has changed by +$5.56B (+9.75%)
What is Novartis AG quarterly total liabilities?
The current quarterly total liabilities of NVS is $62.34B
What is the all time high quarterly total liabilities for Novartis AG?
Novartis AG all-time high quarterly total liabilities is $90.64B
What is Novartis AG quarterly total liabilities year-on-year change?
Over the past year, NVS quarterly total liabilities has changed by +$6.74B (+12.12%)